Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry

Starting soon

Conditions studied: Pancreas Cancer, Hepatocellular Carcinoma, Lung Cancer, Ovarian Cancer, Breast Cancer, Head and Neck Cancer, Colon Cancer, Bladder Cancer, Other Cancer

In brief

The purpose of this clinical trial is to evaluate whether volatile organic compound (VOC) signatures detected in the breath of patients with cancer can serve as a potential screening tool for the early detection of cancer.

Key facts

Study ID

NCT07732686

Run by

University of Oklahoma

People needed

2000

Starts

2026-10-01

Expected to finish

2029-10-01

Last updated by the study team

2026-07-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age ≥ 18 at the time of consent. Male and female patients to be tested.
• Capable of understanding written and/or spoken English language.
• Able to provide informed consent.
• Cancer of any type.
• Newly diagnosed cancer and untreated or established diagnosis of cancer. For established cancer patients, no active anti-cancer treatment for more than one month (reasons for no treatment are such as relapse, progression of cancer, refractory, or intolerance to treatment etc.)

You may not qualify if…

• Under the age of 18.
• Anticipated inability to complete breath sampling procedure.
• Unable to provide informed consent.
• Pregnant women
• Active respiratory infection symptoms
• Recent use of antibiotics
• Difficulty in performing coached exhalation
• Individuals who are unable to follow the instructions
• Cancer patients who are on active treatment for cancer or have received cancer treatment within one month

Where it is running

• OU Health Stephenson Cancer Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.